Cargando…
Differential expression of miRNAs as biomarkers for predicting the outcomes of diffuse large B-cell lymphoma patients
Background: Diffuse large B-cell lymphoma (DLBCL) used to be defined as germinal center B-like and non-germinal center B-like subtypes, associated with different prognoses, but the conventional classification does not meet the needs of clinical practice because of DLBCL heterogeneity, a problem that...
Autores principales: | Hu, Maogui, Wang, Xinchen, Liu, Ning, Ding, Kaiyang, Zhang, Guihong, Liu, Xiaosi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Portland Press Ltd.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8239963/ https://www.ncbi.nlm.nih.gov/pubmed/34109978 http://dx.doi.org/10.1042/BSR20201551 |
Ejemplares similares
-
Circulating miRNAs as biomarkers in diffuse large B-cell lymphoma: a systematic review
por: Lopez-Santillan, Maria, et al.
Publicado: (2018) -
Expression Analysis of miRNAs and Their Potential Role as
Biomarkers for Prostate Cancer Detection
por: Bergez-Hernández, Fernando, et al.
Publicado: (2022) -
Exosomal miRNAs as biomarkers for diagnostic and prognostic in lung cancer
por: Wu, Jing, et al.
Publicado: (2020) -
Differential expression of miRNAs in the serum of patients with high-risk oral lesions
por: MacLellan, Sara Ann, et al.
Publicado: (2012) -
Next‐generation sequencing of miRNAs in clinical samples of Epstein–Barr virus‐associated B‐cell lymphomas
por: Sakamoto, Kouta, et al.
Publicado: (2017)